Kidney Failure in Indonesia: Causes, Rising Costs, and Treatment Options

Indonesia faces a growing public health crisis as chronic kidney disease (CKD) rates surge, driven largely by preventable lifestyle factors such as excessive salt consumption, uncontrolled hypertension, and rising diabetes prevalence. Recent reports indicate that over 10 million Indonesians now live with some form of kidney impairment, with end-stage renal disease (ESRD) cases increasing by nearly 15% annually—a trend mirrored across Southeast Asia but exacerbated locally by dietary habits and limited access to early screening. This escalating burden not only strains the national healthcare system but likewise imposes significant economic costs, with BPJS Kesehatan reporting dialysis-related expenditures exceeding Rp13 trillion in 2025 alone.

Key Clinical Takeaways:

• High sodium intake, prevalent in traditional Indonesian diets, is a major modifiable risk factor for hypertension-induced kidney damage.
• Early detection through routine urine albumin and serum creatinine testing can delay CKD progression by up to 40% in high-risk individuals.
• Integrated care models combining endocrinology, nephrology, and primary care show promise in reducing ESRD incidence among diabetic populations.

The pathophysiology of CKD in this context often begins with endothelial dysfunction caused by chronic hyperglycemia or sustained hypertension, leading to glomerular hyperfiltration, fibrosis, and eventual loss of nephron function. Unlike acute kidney injury, which may be reversible, CKD progresses silently over years, with symptoms like fatigue, edema, and decreased urine output appearing only after significant functional decline. By the time patients require renal replacement therapy—whether hemodialysis, peritoneal dialysis, or transplantation—irreversible damage has typically occurred, underscoring the importance of primordial and primary prevention strategies.

According to a 2024 longitudinal study published in The Lancet Regional Health – Southeast Asia, which followed 15,000 Indonesian adults aged 40–75 over five years, individuals consuming more than 5 grams of sodium per day had a 2.3-fold higher risk of developing stage 3 or worse CKD compared to those adhering to WHO-recommended limits (<2 g/day). The study, funded by the Indonesia Endowment Fund for Education (LPDP) in collaboration with the University of Indonesia’s Faculty of Medicine, also found that only 12% of participants with hypertension achieved adequate blood pressure control (<130/80 mmHg), highlighting critical gaps in chronic disease management.

“We are seeing a tsunami of preventable kidney failure driven by dietary patterns and undiagnosed metabolic disease. Without systemic intervention in primary care and food policy, the dialysis burden will turn into unsustainable.”

Further complicating the landscape is the rising incidence of diabetic kidney disease (DKD), now accounting for nearly half of all new ESRD cases in urban centers like Jakarta and Surabaya. A 2023 analysis by the Indonesian Society of Nephrology revealed that DKD patients are, on average, a decade younger than non-diabetic CKD counterparts, suggesting a shift toward earlier onset of metabolic complications. This trend aligns with global data from the IDF Diabetes Atlas, which notes Southeast Asia has the highest relative increase in diabetes prevalence worldwide.

Despite these challenges, emerging models of integrated care offer hope. Pilot programs in Yogyakarta and Bandung that co-locate endocrinologists, nephrologists, dietitians, and primary care physicians within community health centers have demonstrated a 30% reduction in referrals for dialysis initiation over two years. These programs emphasize structured lifestyle intervention, regular point-of-care testing, and patient education—particularly around reading food labels and modifying traditional recipes to reduce salt and sugar content.

For individuals at risk due to family history, obesity, or diagnosed hypertension or diabetes, proactive engagement with specialized care is essential. Routine screening should include annual urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) assessments, especially for those over 40 or with comorbidities. Patients exhibiting early signs of kidney dysfunction—such as persistent microalbuminuria or uncontrolled blood pressure despite monotherapy—should seek timely evaluation.

It is strongly recommended to consult with vetted board-certified nephrologists who can guide personalized risk stratification and intervene before irreversible damage occurs. Managing comorbid conditions often requires coordinated input. those struggling with glycemic control may benefit from consultation with certified endocrinologists experienced in diabetes-kidney axis therapeutics, including SGLT2 inhibitors and finerenone, which have shown robust renal protection in landmark trials like DAPA-CKD and FIDELIO-DKD.

From a systemic standpoint, addressing this epidemic demands more than clinical vigilance—it requires policy action. Successful sodium reduction strategies in countries like Finland and the UK demonstrate that mandatory food labeling, reformulation of processed foods, and public awareness campaigns can significantly lower population-level sodium intake. Indonesia’s recent regulation capping sodium in instant noodles is a step forward, but broader enforcement across street food vendors, traditional markets, and home cooking practices remains inconsistent.

As the nation grapples with this silent epidemic, the focus must shift from reactive treatment to proactive prevention. Investing in early detection infrastructure, expanding access to guideline-directed medical therapy, and empowering communities with culturally resonant health education are not just clinical imperatives—they are economic and ethical necessities. The trajectory of Indonesia’s renal health will depend not on breakthrough therapies alone, but on the collective ability to translate evidence into everyday practice.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.